Literature DB >> 25377543

Grading of peripheral cytopenias caused by nonalcoholic cirrhotic portal hypertension and its clinical significance.

Yunfu Lv1, Xiaoyu Han, Xiaoguang Gong, Qingyong Ma, Shunwu Chang, Hongfei Wu, Yejuan Li, Jie Deng.   

Abstract

This study investigates peripheral cytopenias in patients with splenomegaly caused by nonalcoholic cirrhotic portal hypertension. Data from 330 splenomegaly cases caused by nonalcoholic cirrhotic portal hypertension were collected and analyzed using univariate and multivariate analysis. The cytopenias were scored and graded according to the F value of the multiple linear regression equation. Based on the severity of thrombocytopenia, cytopenia was graded as mild, moderate, or severe, and determined by a score of <2 points, 2-3 points, and >3 points. 30 % of the patients had monolineage cytopenias, 35.8 % had bilineage cytopenias, and 34.2 % had trilineage cytopenias. All patients were treated surgically. In the univariate analysis, the severity of erythropenia was different in the surgical outcome when compared to the intra-group (P < 0.05). In the multivariate analysis, thrombocytopenia was different in the surgical outcomes when compared with leukopenia and erythropenia (P < 0.05). There was a significant difference in surgical outcomes between the three grades (mild, moderate, and severe) of cytopenia (P < 0.05). Peripheral cytopenias have a significant impact on the clinical outcomes. The more severe the cytopenias, the worse the surgical outcomes are. Thrombocytopenia is a major factor influencing surgical outcomes. The thrombocytopenia-based three-level grading of cytopenias provides a basis for analyzing individual cases, planning treatment, and assessing prognosis in clinical practice.

Entities:  

Mesh:

Year:  2015        PMID: 25377543     DOI: 10.1007/s12013-014-0321-x

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  5 in total

1.  Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.

Authors:  Yunfu Lv; Wan Yee Lau; Hongfei Wu; XiaoYu Han; Xiaoguang Gong; Ning Liu; Jie Yue; Qingqing Li; YeJuan Li; Jie Deng
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

2.  Hypersplenism: History and current status.

Authors:  Yunfu Lv; Wan Yee Lau; Yejuan Li; Jie Deng; Xiaoyu Han; Xiaoguang Gong; Ning Liu; Hongfei Wu
Journal:  Exp Ther Med       Date:  2016-09-07       Impact factor: 2.447

3.  Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance.

Authors:  Xiaoyu Han; Yunfu Lv; Yejuan Li; Jie Deng; Qingan Qiu; Ning Liu; Shuya Zhao; Caixian Liao
Journal:  J Int Med Res       Date:  2018-05-20       Impact factor: 1.671

4.  Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic rats.

Authors:  Yunfu Lv; Yejuan Li; Ning Liu; Yonghong Dong; Jie Deng
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

5.  Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension.

Authors:  Abdurrahman Sahin; Hakan Artas; Nurettin Tunc; Mehmet Yalniz; Ibrahim Halil Bahcecioglu
Journal:  J Clin Med       Date:  2018-08-02       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.